IL143562A0 - Immunosuppression - Google Patents

Immunosuppression

Info

Publication number
IL143562A0
IL143562A0 IL14356299A IL14356299A IL143562A0 IL 143562 A0 IL143562 A0 IL 143562A0 IL 14356299 A IL14356299 A IL 14356299A IL 14356299 A IL14356299 A IL 14356299A IL 143562 A0 IL143562 A0 IL 143562A0
Authority
IL
Israel
Prior art keywords
immunosuppression
Prior art date
Application number
IL14356299A
Other languages
English (en)
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9827921.9A external-priority patent/GB9827921D0/en
Priority claimed from GBGB9925015.1A external-priority patent/GB9925015D0/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of IL143562A0 publication Critical patent/IL143562A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14356299A 1998-12-19 1999-12-17 Immunosuppression IL143562A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827921.9A GB9827921D0 (en) 1998-12-19 1998-12-19 Immunosuppression
GBGB9925015.1A GB9925015D0 (en) 1999-10-23 1999-10-23 Immunosuppression
PCT/GB1999/004200 WO2000037102A2 (fr) 1998-12-19 1999-12-17 Immunosuppression

Publications (1)

Publication Number Publication Date
IL143562A0 true IL143562A0 (en) 2002-04-21

Family

ID=26314866

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14356299A IL143562A0 (en) 1998-12-19 1999-12-17 Immunosuppression

Country Status (15)

Country Link
US (1) US20060134124A1 (fr)
EP (1) EP1140153A2 (fr)
JP (1) JP2002532115A (fr)
CN (1) CN1189213C (fr)
AU (1) AU776618B2 (fr)
CA (1) CA2353960A1 (fr)
CZ (1) CZ20011896A3 (fr)
HK (1) HK1042040A1 (fr)
HU (1) HUP0104785A2 (fr)
IL (1) IL143562A0 (fr)
NO (1) NO20013020L (fr)
NZ (1) NZ512196A (fr)
PL (1) PL349315A1 (fr)
TR (1) TR200101785T2 (fr)
WO (1) WO2000037102A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810127D0 (en) * 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
US7883855B2 (en) 2006-07-21 2011-02-08 Abbott Laboratories Immunosuppressant drug extraction reagent for immunoassays
US7914999B2 (en) 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
EP2232264B1 (fr) * 2007-12-19 2015-12-02 Abbott Laboratories Réactif d'extraction d'un immunosuppresseur pour dosages immunologiques
KR101417345B1 (ko) * 2012-09-19 2014-07-08 기아자동차주식회사 연료전지 시스템의 제어 방법
SG11201604868YA (en) 2013-12-16 2016-07-28 Us Health Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
JP6830437B2 (ja) 2014-12-10 2021-02-17 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 疾患を処置するための遺伝子改変された細胞、組織および臓器
US20180064792A1 (en) * 2015-03-30 2018-03-08 Osaka University Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disease containing same, and method for treating immune disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007896A1 (fr) * 1986-06-20 1987-12-30 Scripps Clinic And Research Foundation Epitopes des cellules t et b de la region pre-s de l'antigene de surface du virus de l'hepatite b
US5489533A (en) * 1987-05-04 1996-02-06 Dana Farber Cancer Institute Isolated nucleic acid molecules encoding ICAM-2
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
WO1997011971A1 (fr) * 1995-09-28 1997-04-03 Alexion Pharmaceuticals, Inc. Proteines d'interaction de cellules porcines
AU721729B2 (en) * 1996-05-01 2000-07-13 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis

Also Published As

Publication number Publication date
CN1189213C (zh) 2005-02-16
AU776618B2 (en) 2004-09-16
CN1331603A (zh) 2002-01-16
PL349315A1 (en) 2002-07-15
CA2353960A1 (fr) 2000-06-29
NO20013020L (no) 2001-08-17
HUP0104785A2 (hu) 2002-04-29
AU1987500A (en) 2000-07-12
CZ20011896A3 (cs) 2002-01-16
WO2000037102A2 (fr) 2000-06-29
WO2000037102A3 (fr) 2000-09-14
EP1140153A2 (fr) 2001-10-10
TR200101785T2 (tr) 2001-10-22
US20060134124A1 (en) 2006-06-22
NZ512196A (en) 2004-12-24
JP2002532115A (ja) 2002-10-02
NO20013020D0 (no) 2001-06-18
HK1042040A1 (zh) 2002-08-02

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69914921D1 (en) Phenyl-xanthinderivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69934603D1 (en) Elektrophotographischer photoconduktor
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69904442D1 (en) Cyclohexandiol-derivate
DE69905001D1 (en) Koagulationsvorrichtung
DE59904407D1 (en) Chromanderivate
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
PL349315A1 (en) Immunosuppression
DE69821502D1 (en) Boroskop
DE59900495D1 (en) Multimetalloxidmassen
HUP0105165A3 (en) Lichting arrangement
GB9808496D0 (en) Resistance-monitoring arrangement
DE59900471D1 (en) Inchbremseinrichtung
DE69912430D1 (en) Hydroformylierungsreaktionen